SightfileU.S. market data from official filings

ABSCI CORPORATION (ABSI)

Name: ABSCI CORPORATION (ABSI) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001672688 · EDGAR filings · Updated 2026-07-06

ABSCI CORPORATION (ABSI) has reported institutional ownership of 82.5%, with 164 institutional managers holding positions valued at $378.6M per the latest 13F reporting period.

Institutional ownership

82.5%

Institutional managers

164

Reported 13F value

$378.6M

Insider activity

46 trans.

$885.0K net buying

Latest updates

2026-07-06 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-24 — Current report (8-K) filed
2026-06-24 — Prospectus supplement (424B5) filed
2026-06-24 — Current report (8-K) filed
2026-06-15 — 4/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ABSCI CORPORATION has 164 institutional holders and institutional ownership of 82.5%.

Insider activity

Insiders reported 46 transactions (6 buys, 2 sells) across 10 reporting insiders, with a net reported value of $885.0K.

Related companies

ZEVRA THERAPEUTICS INC (ZVRA) · ENGENE HOLDINGS INC (ENGN) · CRYOPORT INC (CYRX) · ASSEMBLY BIOSCIENCES INC (ASMB) · X4 PHARMACEUTICALS INC (XFOR) · CYTEK BIOSCIENCES INC (CTKB)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.